JP2001520515A - 再発性前立腺癌の検出のための方法 - Google Patents

再発性前立腺癌の検出のための方法

Info

Publication number
JP2001520515A
JP2001520515A JP54402298A JP54402298A JP2001520515A JP 2001520515 A JP2001520515 A JP 2001520515A JP 54402298 A JP54402298 A JP 54402298A JP 54402298 A JP54402298 A JP 54402298A JP 2001520515 A JP2001520515 A JP 2001520515A
Authority
JP
Japan
Prior art keywords
dna
rna
sample
cells
amplified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP54402298A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001520515A5 (enExample
Inventor
エム． スラウィン，ケビン
ジェイ． ティンダール，ドナルド
ワイ．エフ． ヤング，チャールズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Mayo Foundation for Medical Education and Research
Original Assignee
Baylor College of Medicine
Mayo Clinic in Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine, Mayo Clinic in Florida filed Critical Baylor College of Medicine
Publication of JP2001520515A publication Critical patent/JP2001520515A/ja
Publication of JP2001520515A5 publication Critical patent/JP2001520515A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP54402298A 1997-04-11 1998-04-09 再発性前立腺癌の検出のための方法 Ceased JP2001520515A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/843,076 US6479263B1 (en) 1996-11-14 1997-04-11 Method for detection of micrometastatic prostate cancer
US08/843,076 1997-04-11
PCT/US1998/007027 WO1998046795A1 (en) 1997-04-11 1998-04-09 Method for detection of recurrent prostate cancer

Publications (2)

Publication Number Publication Date
JP2001520515A true JP2001520515A (ja) 2001-10-30
JP2001520515A5 JP2001520515A5 (enExample) 2005-11-24

Family

ID=25289029

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54402298A Ceased JP2001520515A (ja) 1997-04-11 1998-04-09 再発性前立腺癌の検出のための方法

Country Status (4)

Country Link
US (2) US6479263B1 (enExample)
JP (1) JP2001520515A (enExample)
AU (1) AU6958498A (enExample)
WO (1) WO1998046795A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2324503T3 (es) 1997-04-10 2009-08-07 Stichting Katholieke Universiteit University Medical Centre Nijmegen Pca3, genes pca3 y metodos de uso.
US20050003394A1 (en) * 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US7473528B2 (en) * 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20040265868A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
US20060134635A1 (en) * 2001-02-28 2006-06-22 Chondrogene Limited Method for the detection of coronary artery disease related gene transcripts in blood
WO2000040749A2 (en) * 1999-01-06 2000-07-13 Genenews Inc. Method for the detection of gene transcripts in blood and uses thereof
US20040241728A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US20040248170A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
US20040248169A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US20070105121A1 (en) * 1999-01-06 2007-05-10 Chondrogene Limited Method for the detection of schizophrenia related gene transcripts in blood
EP1151142A2 (en) * 1999-01-28 2001-11-07 Gen-Probe Incorporated Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
WO2000049158A2 (en) * 1999-02-18 2000-08-24 Compugen Ltd. Psa and klk-2 splicing variants
FI990382A0 (fi) * 1999-02-23 1999-02-23 Arctic Partners Oy Ab Uusi diagnostinen menetelmä
AU7627200A (en) * 1999-07-29 2001-02-19 Johns Hopkins University, The Activation of peptide prodrugs by hk2
JP2003510075A (ja) * 1999-09-29 2003-03-18 ディグノキュアー・インコーポレーテッド 良性および悪性の前立腺組織におけるｐｃａ３メッセンジャーｒｎａ種
FR2810677B1 (fr) * 2000-06-27 2004-10-01 Urogene Procede de diagnostic in vitro du cancer de la prostate et kit de mise en oeuvre
EP1174502A1 (en) * 2000-07-18 2002-01-23 Schering Corporation Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
US20050112705A1 (en) * 2002-03-14 2005-05-26 Laurent Bracco Variants of human kallikrein-2 and kallikrein-3 and uses thereof
JP4824540B2 (ja) 2003-02-07 2011-11-30 ダイアノキュアー インク． サンプル中の前立腺癌を検出する方法
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
US20090061456A1 (en) * 2007-08-30 2009-03-05 Allard William J Method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells
US20090117532A1 (en) * 2007-11-01 2009-05-07 Doyle Gerald V Pre-clinical method for monitoring serial changes in circulating breast cancer cells in mice
US20090191535A1 (en) * 2007-12-22 2009-07-30 Mark Carle Connelly Method of assessing metastatic carcinomas from circulating endothelial cells and disseminated tumor cells
CA2731823A1 (en) * 2008-07-25 2010-01-28 The Johns Hopkins University Detection of prostate cancer using psa glycosylation patterns
MX338883B (es) 2010-07-27 2016-05-04 Genomic Health Inc Metodo para usar expresion de gen para determinar el pronostico de cancer de prostata.
CN110050074A (zh) * 2016-10-05 2019-07-23 新西兰皇家环境科学研究院 用于体液鉴定的rna序列

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3862925A (en) 1973-07-05 1975-01-28 American Home Prod Preparation of somatotropin release inhibiting factor and intermediates therefor
US3842067A (en) 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates
JPS5726506B2 (enExample) 1974-03-08 1982-06-04
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US4105602A (en) 1975-02-10 1978-08-08 Armour Pharmaceutical Company Synthesis of peptides with parathyroid hormone activity
US4092408A (en) 1975-08-28 1978-05-30 New England Nuclear Corporation Method for solid phase immunological assay of antigen
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4371515A (en) 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate
US4446122A (en) 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US4353982A (en) 1980-04-10 1982-10-12 Hoffmann-La Roche Inc. Immunochemical assay for creatine kinase-MB isoenzyme
US4792528A (en) 1982-05-21 1988-12-20 The Trustees Of Columbia University In The City Of New York Methods for obtaining monoclonal antibodies useful in enhanced sensitivity immunoassays
US4487715A (en) 1982-07-09 1984-12-11 The Regents Of The University Of California Method of conjugating oligopeptides
US4629783A (en) 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4757048A (en) 1985-11-05 1988-07-12 Biotechnology Research Associates J.V. Synthetic analogs of atrial natriuretic peptides
JP2574269B2 (ja) 1985-12-17 1997-01-22 イ−スタン・バ−ジニア・メデイカル・オ−ソリテイ ヒト前立腺腫瘍関連抗原に対する結合特異性を有するモノクロ−ナル抗体類およびそれらを使用する方法
WO1989000192A1 (en) 1987-06-30 1989-01-12 Amgen Inc. Production of kallikrein
CA2096497A1 (en) * 1992-05-26 1993-11-27 Patricia Anne Spears Mycobacteria probes
US5321684A (en) 1992-09-15 1994-06-14 Sri International Bidirectional sinusoidal scanning system
WO1994010343A1 (en) 1992-10-29 1994-05-11 Thomas Jefferson University Methods of detecting micrometastasis of prostate cancer
GB9309966D0 (en) 1993-05-14 1993-06-30 Nordion Int Inc Detection of prostrate-specific antigen in breast tumors
US6103237A (en) 1993-07-22 2000-08-15 Hybritech Incorporated Stable variant hK2 polypeptide
US5516639A (en) 1993-07-22 1996-05-14 Mayo Foundation For Medical Education And Research Antibodies specific for human prostate glandular kallkrein
US5935818A (en) 1995-02-24 1999-08-10 Sloan-Kettering Institute For Cancer Research Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof
EP0760006A1 (en) 1994-04-15 1997-03-05 The Trustees Of Columbia University In The City Of New York Method for molecular staging of prostate cancer
JPH10500294A (ja) * 1994-05-10 1998-01-13 マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ 組換え型ｈｋ２ポリペプチド
AU4897896A (en) 1995-01-04 1996-07-24 Trustees Of Boston University Primers for the pcr amplification of metastatic sequences
US7037647B1 (en) 1995-02-24 2006-05-02 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
US5614372A (en) 1995-02-24 1997-03-25 Lilja; Hans Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)
GB2302874B (en) 1995-06-29 1999-11-10 Orion Yhtymae Oy Novel proteins
WO1997007242A1 (en) 1995-08-16 1997-02-27 Steven Lehrer Method for detecting circulating breast cancer cells
WO1998002748A1 (en) 1996-07-15 1998-01-22 Mayo Foundation For Medical Education And Research Methods to detect hk2 polypeptides

Also Published As

Publication number Publication date
WO1998046795A1 (en) 1998-10-22
AU6958498A (en) 1998-11-11
US20030113743A1 (en) 2003-06-19
US6479263B1 (en) 2002-11-12

Similar Documents

Publication Publication Date Title
JP2001520515A (ja) 再発性前立腺癌の検出のための方法
US6225103B1 (en) Cloning and characterization of napsin
JPH10500294A (ja) 組換え型ｈｋ２ポリペプチド
AU719502B2 (en) Stable variant HK2 polypeptide
WO1995030758A9 (en) Recombinant hk2 polypeptide
WO1998022597A9 (en) Cloning and characterization of napsin, an aspartic protease
AU739546B2 (en) Forms of prostate specific antigen and methods for their detection
AU737659B2 (en) Method for detection of metastatic prostate cancer
EP0974057B1 (en) Methods to detect hk2 polypeptides
CZ417897A3 (cs) Lidský žlázový kallikrein-1 (hk2)
WO1998002748A9 (en) Methods to detect hk2 polypeptides
JP2002538818A (ja) 前立腺腫瘍組織におけるヒトカリクレイン２とプロテアーゼインヒビター−６の新規な複合体および該複合体の利用方法
AU767187B2 (en) Novel serine protease BSSP6
US20040259113A1 (en) Method for detection of metastatic prostate cancer
MXPA99004504A (en) Method for detection of metastatic prostate cancer
MXPA99000659A (es) Metodos para detectar polipeptidos de hk2

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050405

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050405

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070605

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20071024

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20071204